Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views

11mon ago, source: Hosted on MSN

Shares of Rain Oncology Inc (NASDAQ: RAIN) recovered in early trading on Tuesday, after having plummeted on disappointing cancer study data. Here are some key analyst takeaways from the company ...

Lexaria Appoints Nelson Cabatuan as Chief Financial Officer

1mon ago, source: Morningstar

Mr. Cabatuan has over 15 years of corporate finance and operations experience within the life sciences industry, most recently serving as SVP Finance and Operations at Rain Oncology, Inc., a late ...

Universal Logistics Holdings Reports First Quarter 2024 Financial Results; Declares Dividend

20m ago, source:

Universal Logistics Holdings, Inc. (NASDAQ: ULH) today reported consolidated first quarter 2024 net income of $52.5 million, ...

ELEV Elevation Oncology, Inc.

5d ago, source: Seeking Alpha

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.

PYXS Pyxis Oncology, Inc.

2d ago, source: Seeking Alpha

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Predictive Oncology Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CG Oncology, Inc.

2mon ago, source: CNN

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer.

Oncology Pharma Inc ONPH

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pyxis Oncology Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Elevation Oncology, Inc.

11mon ago, source: CNN

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations.